Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist - PubMed (original) (raw)
Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist
James G Pfaus et al. Proc Natl Acad Sci U S A. 2004.
Abstract
Disorders of sexual desire affect an estimated 30% of women in North America and Europe, with etiologies based on interpersonal, personal, and physiological factors. There are currently no pharmacological agents approved for use in the treatment of female sexual dysfunction. This is due, in part, to a focus on the effects of experimental drugs on reflexive components of sexual behavior, such as lordosis, in animal models. Here we report that PT-141, a peptide analogue of alpha-melanocyte-stimulating hormone that binds to central melanocortin receptors, selectively stimulates solicitational behaviors in the female rat. This occurs without affecting lordosis, pacing, or other sexual behaviors. PT-141 did not cause generalized motor activation, nor did it affect the perception of sexual reward. A selective pharmacological effect on appetitive sexual behavior in female rats has not been reported previously, and indicates that central melanocortin systems are important in the regulation of female sexual desire. Accordingly, PT-141 may be the first identified pharmacological agent with the capability to treat female sexual desire disorders.
Figures
Fig. 1.
Pacing chambers used to assess female sexual behavior in the present experiments. (Upper) Copulation in bilevel chambers, initiated by solicitation (1), followed by anogenital investigation of the female (2), a runaway by the female to the other level (3), enticing the male to chase her, and finally the display of lordosis by the female (4), which allowed the male to mount with vaginal intromission. (Lower) Copulation in unilevel pacing chambers. The female on the left is crawling through a hole in a central partition to initiate copulation with the male. The female on the right has just been mounted.
Fig. 2.
Dose–response effects of PT-141 on sexual behavior in bilevel chambers. (Top) Effects on solicitations in females primed with estrogen and progesterone (E+P) or estrogen alone (E alone). For E+P-treated females, _F_3,35 = 3.73, P < 0.02. For females treated with E alone, _F_1,37 = 5.52, P < 0.03. Post hoc tests revealed that both the 100- and 200-μg/kg doses increased the number of solicitations significantly compared to saline-treated controls (P values < 0.05). (Middle) Effects on pacing in females primed with E+P or E alone. (Bottom) Effects on lordosis quotients in females primed with E+PorE alone. Data are means + SEM. *, P < 0.05 from control.
Fig. 3.
Dose–response effects of PT-141 on the sexual behavior of E+P-primed female rats in unilevel pacing chambers. (Top Left) Effects on solicitations (_F_3,34 = 6.62, P < 0.002). (Top Right) Effects on hops and darts (_F_3,34 = 4.12, P < 0.02). Post hoc tests revealed that both the 100- and 200-μg/kg doses increased solicitation and hops and darts significantly (P values < 0.05). (Middle Left) Effects on lordosis quotients. (Middle Right) Effects on female mounting of the male (FMM). _F_3,34 = 3.84, P < 0.02. Post hoc tests revealed a significant effect of the highest dose only (P < 0.05). (Bottom Left) Effects on the intromission return latency. (Bottom Right) Effects on the ejaculation return latency). _F_3,34 = 3.65, P < 0.02. Post hoc tests revealed a significant effect of the 100- and 200-μg/kg doses (P values < 0.05) Data are means ± SEM. *, P < 0.05 from control.
Fig. 4.
Effects of PT-141 or saline on locomotion and CPP. (Upper) Effects of saline or PT-141 (200 μg/kg) on the number of grid crossings in an open field during a 15-min test of locomotor activity. (Lower) Effects of PT-141 or saline on CPP induced by sequential paring of copulation in the one-hole versus four-hole condition. Data are means + SEM. *, P < 0.05 from pretest.
Comment in
- Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist.
Seftel A. Seftel A. J Urol. 2005 Apr;173(4):1279-80. J Urol. 2005. PMID: 15758778 No abstract available.
Similar articles
- The melanocortin agonist, melanotan II, enhances proceptive sexual behaviors in the female rat.
Rössler AS, Pfaus JG, Kia HK, Bernabé J, Alexandre L, Giuliano F. Rössler AS, et al. Pharmacol Biochem Behav. 2006 Nov;85(3):514-21. doi: 10.1016/j.pbb.2006.09.023. Epub 2006 Nov 20. Pharmacol Biochem Behav. 2006. PMID: 17113634 - Bremelanotide: an overview of preclinical CNS effects on female sexual function.
Pfaus J, Giuliano F, Gelez H. Pfaus J, et al. J Sex Med. 2007 Nov;4 Suppl 4:269-79. doi: 10.1111/j.1743-6109.2007.00610.x. J Sex Med. 2007. PMID: 17958619 - An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.
Diamond LE, Earle DC, Heiman JR, Rosen RC, Perelman MA, Harning R. Diamond LE, et al. J Sex Med. 2006 Jul;3(4):628-638. doi: 10.1111/j.1743-6109.2006.00268.x. J Sex Med. 2006. PMID: 16839319 Clinical Trial. - Bremelanotide: First Approval.
Dhillon S, Keam SJ. Dhillon S, et al. Drugs. 2019 Sep;79(14):1599-1606. doi: 10.1007/s40265-019-01187-w. Drugs. 2019. PMID: 31429064 Review. - Melanocortins in the treatment of male and female sexual dysfunction.
Shadiack AM, Sharma SD, Earle DC, Spana C, Hallam TJ. Shadiack AM, et al. Curr Top Med Chem. 2007;7(11):1137-44. doi: 10.2174/156802607780906681. Curr Top Med Chem. 2007. PMID: 17584134 Review.
Cited by
- From Parental Behavior to Sexual Function: Recent Advances in Oxytocin Research.
Dale Ii J, Harberson MT, Hill JW. Dale Ii J, et al. Curr Sex Health Rep. 2024;16(3):119-130. doi: 10.1007/s11930-024-00386-1. Epub 2024 May 11. Curr Sex Health Rep. 2024. PMID: 39224135 Free PMC article. Review. - Being friendly: paced mating for the study of physiological, behavioral, and neuroplastic changes induced by sexual behavior in females.
Ventura-Aquino E, Paredes RG. Ventura-Aquino E, et al. Front Behav Neurosci. 2023 Sep 28;17:1184897. doi: 10.3389/fnbeh.2023.1184897. eCollection 2023. Front Behav Neurosci. 2023. PMID: 37840548 Free PMC article. Review. - Melanocortin 4 receptor signaling in Sim1 neurons permits sexual receptivity in female mice.
Semple EA, Harberson MT, Xu B, Rashleigh R, Cartwright TL, Braun JJ, Custer AC, Liu C, Hill JW. Semple EA, et al. Front Endocrinol (Lausanne). 2023 Mar 24;14:983670. doi: 10.3389/fendo.2023.983670. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37033219 Free PMC article. - Melanocortin receptor 3 and 4 mRNA expression in the adult female Syrian hamster brain.
Hall MAL, Kohut-Jackson AL, Peyla AC, Friedman GD, Simco NJ, Borland JM, Meisel RL. Hall MAL, et al. Front Mol Neurosci. 2023 Feb 23;16:1038341. doi: 10.3389/fnmol.2023.1038341. eCollection 2023. Front Mol Neurosci. 2023. PMID: 36910260 Free PMC article. - Flexibility of neural circuits regulating mating behaviors in mice and flies.
Karigo T, Deutsch D. Karigo T, et al. Front Neural Circuits. 2022 Nov 8;16:949781. doi: 10.3389/fncir.2022.949781. eCollection 2022. Front Neural Circuits. 2022. PMID: 36426135 Free PMC article. Review.
References
- Dornan, W. A. & Malsbury, C. W. (1989) Neurosci. Biobehav. Rev. 13, 1-15. - PubMed
- Pfaus, J. G. & Everitt, B. J. (1995) in Psychopharmacology: The Fourth Generation of Progress, eds. Bloom, F. E. & Kupfer, D. J. (Raven, New York), pp. 743-758
- Pfaus, J. G. & Gorzalka, B. B. (1987) Neurosci. Biobehav. Rev. 11, 1-34. - PubMed
- Cragniolini, A., Scimonelli, T., Cellis, M. E. & Schioth, H. B. (2000) Peptides 34, 211-215. - PubMed
- Raible, L. H. & Gorzalka, B. B. (1986) Peptides 7, 581-586. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources